Rocket Pharmaceuticals, Inc. Common Stock | RCKT

Daily Technical Analysis of Rocket Pharmaceuticals, Inc. Common Stock

Not too much action today, Rocket Pharmaceuticals drifted down slightly. We'll see where it goes next.

Currently RCKT isn't at a clear support/resistance line that seems tradable. Rocket Pharmaceuticals hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the Biotechnology company has lost -29.63 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. RCKT might find some support at the 21.52 level, buyers might push the price back up from here. But it's not very clear what will happen.

Analyst Ratings for Rocket Pharmaceuticals By Price Target And Rating

The analysts feel fairly neutral on the prospects for Rocket Pharmaceuticals but a little more positive than negative. The current Analysts Sentiment Score is 11.37. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-03-01 UBS Group lowered their price target by -3.57% to $54.00. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-02-27 and they set their price target at $65.00. JPMorgan Chase & Co. provided a price target decease of -9.09% to $50.00 from $55.00 on 2024-02-27. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-02-13 and they set their price target at $53.00. On 2023-12-26 there was confirmation of the previous rating by Lifesci Capital which was Outperform. Stifel Nicolaus reiterated a rating of Buy on 2023-09-13 and provided a price target of $48.00. On 2023-08-11 there was confirmation of the previous rating by Chardan Capital which was Buy and added a price target of $61.00. On 2023-08-11 Canaccord Genuity Group lowered their price target by -4.08% to $47.00. William Blair reiterated a rating of Outperform on 2023-03-22.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for Rocket Pharmaceuticals

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for Rocket Pharmaceuticals

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.